Squalane + Peptide Eye Gel

It is ironic that Biossance’s most historically significant product is leaving the lineup. The Squalane + Peptide Eye Gel launched in February 2017 and sold out at Sephora four times in its first few months. This debut proved Biossance was more than a niche biotech curiosity and showed clean beauty products could drive consumer excitement in the competitive eye care category. Nearly a decade later, newer products have nudged the gel aside, but the formula remains one of the most thoughtfully constructed eye treatments in the clean beauty space.

The ingredient architecture uses mechanisms instead of marketing hooks. Two peptides handle different aspects of eye-area aging: acetyl tetrapeptide-5 (Eyeseryl) targets fluid dynamics to reduce under-eye puffiness by lowering vascular permeability and promoting lymphatic drainage, while acetyl hexapeptide-8 (Argireline) addresses expression-driven fine lines by modulating neurotransmitter release at the muscular junction. These are complementary systems targeting distinct problems in the same skin patch.

Niacinamide is fourth in the INCI at a meaningful concentration; it brightens by inhibiting melanin transfer and strengthens the barrier by supporting ceramide synthesis. Both functions matter where the skin is thinnest and the barrier is weakest. Tetrahexyldecyl ascorbate—a stable, oil-soluble vitamin C—provides antioxidant protection and supports collagen synthesis without the instability or stinging of L-ascorbic acid. Caffeine adds to the de-puffing strategy through vasoconstriction while the Eyeseryl peptide handles long-term fluid dynamics.

Biossance’s signature squalane is third in the INCI, providing a lightweight moisture layer so the gel hydrates without heaviness. Sugarcane-derived squalane is structurally identical to the squalene in human sebum, so it integrates into the skin’s lipid matrix without the occlusive feel of petrolatum or the greasiness of plant oils. In a gel for daytime and under-makeup use, this ingredient makes the formula feel effortless rather than medicinal.

The supporting cast includes aloe for soothing, sodium hyaluronate for humectant hydration, panthenol for barrier conditioning, green tea for antioxidant reinforcement, and goji berry and grape skin extracts for antioxidant diversity. It also contains Malus domestica fruit cell culture extract—the Swiss apple stem cells popular in the late 2000s. Evidence for this ingredient’s anti-aging efficacy is limited to a few brand-funded studies; it feels more like a legacy marketing inclusion than a science-forward choice. It does no harm, but it lacks the research pedigree of the peptides and niacinamide.

The gel feels pleasant on the skin. The texture is between a water and a cream—substantial enough to feel like a treatment, but light enough to absorb in under ten seconds without residue, stickiness, or pilling. The airless pump protects the vitamin C and peptides from oxidation and provides hygienic, controlled dispensing. The complete absence of scent—no fragrance, no essential oils, no botanical waters—is refreshing in a category where ‘clean’ products often include lavender or rosemary.

Results vary by concern. De-puffing is the fastest: caffeine and the Eyeseryl peptide reduce morning puffiness within the first week, especially if the gel is stored in the refrigerator and applied cold. Brightening takes three to four weeks as niacinamide and vitamin C affect melanin dynamics. Fine line softening from Argireline is the slowest—expect eight to twelve weeks for visible improvement in expression lines. The gel does not dramatically improve dark circles caused by deep-set bone structure or prominent blood vessels. The niacinamide and vitamin C target pigmentation rather than structural causes.

One quirk: some users report dried, crusty residue around their eyes. This likely comes from the Chondrus crispus (red algae) extract, which forms a thin film that can dry and flake overnight. Using less at night or blotting after application resolves this for most.

The $54 price for 15 milliliters is a significant investment. The formula justifies a premium, but comparable peptide and niacinamide eye treatments cost $20-35, and the packaging feels inexpensive for the price. Since Biossance is phasing this product out for newer offerings, buyers should consider if they want to commit to a product that may not be repurchasable long-term.

As a 2017 document of clean beauty’s direction, this gel is forward-looking. Dual peptides, stable vitamin C, niacinamide as a featured active, no fragrance, pregnancy-safe, and fungal-acne-safe were not standard eye product checkboxes a decade ago. Biossance got the formula right early; the market just needed time to catch up.